# 代表为第一作者
* 代表为通讯作者
Song M#, Ye L#, Yan Y#, Li X, Han X, Hu S*, Yu M*. Mitochondrial Diseases and mtDNA Editing. Genes & Diseases. 2024 May; 11(3): 101057.
Sun Z#, Yang L#, Kiram A#, Yang J#, Yang Z, Xiao L, Yin Y, Liu J, Mao Y, Zhou D, Yu H, Zhou Z, Xu D, Jia Y, Ding C, Guo Q, Wang H, Li Y, Wang L, Fu T*, Hu S*, Gan Z*. FNIP1 abrogation promotes functional revascularization of ischemic skeletal muscle by driving macrophage recruitment. Nat Commun. 2023 Nov 6;14(1):7136.
Li X#, Wu Y#, Ren X#, Wang Y#, Xu Y, Zhao X, Yang J, Li J, Zhang F, Xiao M*, Lei W*, Shen Z*, Hu S*, Tang M*. Topological butterfly wings for human induced pluripotent stem cell-derived cardiomyocyte maturation and myocardial infarction treatment. Chem Eng J. 2023 Sep 1;471:144635.
Xu YJ, Dai SK, Duan CH, Zhang ZH, Liu PP, Liu C, Du HZ, Lu XK, Hu S, Li L, Teng ZQ*, Liu CM*. ASH2L regulates postnatal neurogenesis through Onecut2-mediated inhibition of TGF-β signaling pathway. Cell Death Differ. 2023 Aug;30(8):1943-1956.
Ding F#, Wu H#, Han X#, Jiang X, Xiao Y, Tu Y, Yu M, Lei W*, Hu S*. The miR-148/152 family contributes to angiogenesis of human pluripotent stem cell- derived endothelial cells by inhibiting MEOX2. Mol Ther Nucleic Acids. 2023 Apr 23;32:582-593.
Tang Y#, Feng M#, Su Y, Ma T, Zhang H, Wu H, Wang X, Shi S, Zhang Y, Xu Y, Hu S, Wei K*, Xu D*. Jmjd4 Facilitates Pkm2 Degradation in Cardiomyocytes and Is Protective Against Dilated Cardiomyopathy. Circulation. 2023 May 30;147(22):1684-1704.
Li J#, Yang J#, Zhao D, Lei W*, Hu S*. Promises and challenges of cardiac organoids. Mamm Genome. 2023 Jun;34(2):351-356.
Hao KL#, Zhai QC#, Gu Y#, Chen YQ, Wang YN, Liu R, Yan SP, Wang Y, Shi YF, Lei W*, Shen ZY*, Xu Y*, Hu SJ*. Disturbance of suprachiasmatic nucleus function improves cardiac repair after myocardial infarction by IGF2-mediated macrophage transition. Acta Pharmacol Sin. 2023 Aug;44(8):1612-1624.
Zhang G#, Li W#, Yu M#, Huang H, Wang Y, Han Z, Shi K, Ma L, Yu Z, Zhu X, Peng Z, Xu Y, Li X, Hu S, He J, Li D, Xi Y, Lan H*, Xu L*, Tang M*, Xiao M*. Electric-Field-Driven Printed 3D Highly Ordered Microstructure with Cell Feature Size Promotes the Maturation of Engineered Cardiac Tissues. Adv Sci (Weinh). 2023 Feb 13:e2206264.
Wang S#, Tao C#, Mao H, Hou L, Wang Y, Qi T, Yang Y, Ong SG, Hu S*, Chai R*, Wang Y*. Identification of SaCas9 orthologs containing a conserved serine residue that determines simple NNGG PAM recognition. PLoS Biol. 2022 Nov 30;20(11):e3001897.
Xiao Y#, Chen Y#, Shao C#, Wang Y, Hu S*, Lei W*. Strategies to improve the therapeutic effect of pluripotent stem cell-derived cardiomyocytes on myocardial infarction. Front Bioeng Biotechnol. 2022 Aug 5;10:973496.
Li C, Feng Y, Fu Z, Deng J, Gu Y, Wang H, Wu X, Huang Z, Zhu Y, Liu Z, Huang M, Wang T, Hu S, Yao B, Zeng Y, Zhou CJ, Brown SDM, Liu Y, Vidal-Puig A, Dong Y, Xu Y. Human-specific gene CT47 blocks PRMT5 degradation to lead to meiosis arrest. Cell Death Discov. 2022 Aug 2;8(1):345.
Wang Y#, Yu M#, Hao K#, Lei W, Tang M*, Hu S*. Cardiomyocyte Maturation-the Road is not Obstructed. Stem Cell Rev Rep. 2022 Dec;18(8):2966-2981.
Yang Z#, Yu M#, Li X#, Tu Y#, Wang C#, Lei W, Song M, Wang Y, Huang Y, Ding F, Hao K, Han X, Ni X, Qu L*, Shen Z*, Hu S*. Retinoic acid inhibits the angiogenesis of human embryonic stem cell-derived endothelial cells by activating FBP1-mediated gluconeogenesis. Stem Cell Res Ther. 2022 Jun 7;13(1):239.
Yu M, Lan F, Zhao MT, Ye L, Hu S*. Editorial: Stem Cells and Cardiovascular Diseases. Front Cell Dev Biol. 2022 Feb 28;10:862482.
Zhang Y#, Wei J#, Cao J#, Zhang K#, Peng Y, Deng H, Kang J, Pan G, Zhang Y, Fu B, Hu S, Na J, Liu Y, Wang L, Liang L, Zhu H, Zhang Y, Jin ZB, Hao J*, Ma A*, Zhao T*, Yu J*. Requirements for human-induced pluripotent stem cells. Cell Prolif. 2022 Apr;55(4):e13182.
Chen X#, Huang J#, Wu J#, Hao J#, Fu B, Wang Y, Zhou B, Na T, Wei J, Zhang Y, Li Q, Hu S, Zhou J, Yu J, Wu Z, Zhu H, Cao J, Wang L, Peng Y, Liang L, Ma A*, Zhang Y*, Zhao T*, Xiang AP*. Human mesenchymal stem cells. Cell Prolif. 2022 Apr;55(4):e13141.
Nan X#, Zhang B#, Hao J#, Yue W#, Fu B, Qu M, Zhang Y, Wang H, Fang F, Wei J, Li Q, Hu S, Yu J, Gao Y, Liu Q, Cao J, Wang L, Peng Y, Zhu H, Liang L, Ma A*, Zhou J*, Zhao T*, Pei X*. Requirements for human haematopoietic stem/progenitor cells. Cell Prolif. 2022 Apr;55(4):e13152.
Peng Z#, Wu J#, Hu S#, Ma A#, Wang L, Cao N, Zhang Y, Li Q, Yu J, Meng S, Na T, Shi X, Li M, Liu H, Qian L, Tian E, Lin F, Cao J, Peng Y, Zhu H, Liang L, Hao J*, Zhao T*, Cheng X*, Pan G*. Requirments for primary human hepatocyte. Cell Prolif. 2022 Apr;55(4):e13147.
Wang L#, Cao J#, Peng Y#, Fu B#, Jin Z, Hu Y, Wu W, Xiang AP, Hu S, Yu J, Zhang Y, Wei J, Zhang Y, Li Q, Zhou J, Zhai P, Zhu H, Liang L, Ma A*, Stacey G*, Zhao T*, Hao J*. Human retinal pigment epithelial cells. Cell Prolif. 2022 Apr;55(4):e13153.
Yu M#, Lei W#, Cao J#, Wang L#, Ma A, Zhao ZA, Yang HT, Shen Z, Lan F, Cao F, Liang P, Pei X, Xiang AP, Yu J, Zhang Y, Zhang Y, Li Q, Zhou J, Wei J, Peng Y, Zhu H, Liang L, Cao N, Fu B*, Hao J*, Zhao T*, Hu S*. Requirements for human cardiomyocytes. Cell Prolif. 2022 Apr;55(4):e13150.
Ye L#, Yu Y#, Zhao ZA#, Zhao D, Ni X, Wang Y, Fang X, Yu M, Wang Y, Tang JM, Chen Y, Shen Z, Lei W, Hu S*. Patient-specific iPSC-derived cardiomyocytes reveal abnormal regulation of FGF16 in a familial atrial septal defect. Cardiovasc Res. 2022 Feb 21;118(3):859-871.
Ni X, Yang Z, Ye L, Han X, Zhao D, Ding F, Ding N, Wu H, Yu M, Xu GY, Zhao ZA, Lei W, Hu S*. Establishment of an in vitro safety assessment model for lipid-lowering drugs using same-origin human pluripotent stem cell-derived cardiomyocytes and endothelial cells. Acta Pharmacol Sin. 2022 Jan;43(1):240-250.
Wang S, Mao H, Hou L, Hu Z, Wang Y, Qi T, Tao C, Yang Y, Zhang C, Li M, Liu H, Hu S, Chai R*, Wang Y*. Compact SchCas9 Recognizes the Simple NNGR PAM. Adv Sci (Weinh). 2022 Feb;9(4):e2104789.
Yu M, Han X, Ye L, Lei W, Hu S*. Generation of Human Induced Pluripotent Stem Cells from Renal Epithelial Cells. Methods Mol Biol. 2021 Oct 6. doi: 10.1007/7651_2021_419. Online ahead of print.
Han Z#, Xu Z#, Yu Y#, Cao Y, Bao Z, Gao X, Ye D, Yan G, Gong R, Xu J, Zhang L, Ma W, Wang X, Yang F, Lei H, Tian Y, Hu S, Bamba D, Li Y, Li D, Li C, Wang N, Zhang Y, Pan Z*, Yang B*, Cai B*. ALKBH5-mediated m6A mRNA methylation governs human embryonic stem cell cardiac commitment. Mol Ther Nucleic Acids. 2021 May 29;26:22-33.
Yang J#, Ding N#, Zhao D#, Yu Y#, Shao C, Ni X, Zhao ZA, Li Z, Chen J, Ying Z, Yu M*, Lei W*, Hu S*. Intermittent Starvation Promotes Maturation of Human Embryonic Stem Cell-Derived Cardiomyocytes. Front Cell Dev Biol. 2021 Jul 30;9:687769.
Ye L#, Yu Y#, Wang Y, Huang Y, Yu M, Lei W, Tang JM*, Hu S*. Establishment and characterization of a human embryonic stem cell line carrying a heterozygous GATA4 T280M mutation. Stem Cell Res. 2021 May;53:102393.
Jiang X#, Chen Y#, Liu X#, Ye L, Yu M, Shen Z, Lei W*, Hu S*. Uncovering Inherited Cardiomyopathy With Human Induced Pluripotent Stem Cells. Front Cell Dev Biol. 2021 May 17;9:672039.
Wang W#, Lei W#, Jiang L, Gao S, Hu S, Zhao ZG*, Niu CY*, Zhao ZA*. Therapeutic mechanisms of mesenchymal stem cells in acute respiratory distress syndrome reveal potentials for Covid-19 treatment. J Transl Med. 2021 May 10;19(1):198.
Zhao D#, Lei W#, Hu S*. Cardiac organoid - a promising perspective of preclinical model. Stem Cell Res Ther. 2021 May 6;12(1):272.
Wang Y#, Lei W#, Yang J#, Ni X, Ye L, Shen Z*,Hu S*. The updated view on induced pluripotent stem cells for cardiovascular precision medicine. Pflugers Arch. 2021 Feb 17. doi: 10.1007/s00424-021-02530-5
Huang Y#, Wu H#, Han X#, Wu J, Yu M, Zhao ZA, Shen Z, Hu S*, Lei W*. Generation of an EFNB2-2A-mCherry reporter human embryonic stem cell line using CRISPR/Cas9-mediated site-specific homologous recombination. Stem Cell Res. 2021 Apr;52:102241.
Hao J#, Ma A#, Wang L#, Cao J#, Chen S, Wang L, Fu B, Zhou J, Pei X, Zhang Y, Xiang P, Hu S, Li Q, Zhang Y, Xia Y, Zhu H, Stacey G, Zhou Q*, Zhao T*. General requirements for stem cells Cell Prolif. 2020 Nov 4:e12926.
Hao J#, Cao J#, Wang L#, Ma A#, Chen S, Ding J, Wang L, Fu B, Zhang Y, Pei X, Xiang P, Li Q, Zhang Y, Zhou J, Hu S, Yu J, Wei J, Zhu H, Stacey G, Zhao T*, Zhou Q*. Requirements for human embryonic stem cells Cell Prolif. 2020 Oct 19:e12925.
Miao S#, Zhao D#, Wang X#, Ni X#, Fang X#, Yu M, Ye L, Yang J, Wu H, Han X, Qu L, Li L, Lan F*, Shen Z*, Lei W*, Zhao ZA*, Hu S*. Retinoic acid promotes metabolic maturation of human Embryonic Stem Cell-derived Cardiomyocytes. Theranostics. 2020 Aug 1;10(21):9686-9701.
Guo Y#, Yu Y#, Hu S*, Chen Y*, Shen Z*. The therapeutic potential of mesenchymal stem cells for cardiovascular diseases. Cell Death Dis. 2020 May 11;11(5):349.
Wang B#, Xu M#, Li M, Wu F, Hu S, Chen X, Zhao L, Huang Z, Lan F*, Liu D*, Wang Y*. miR-25 Promotes Cardiomyocyte Proliferation by Targeting FBXW7. Mol Ther Nucleic Acids. 2020 Mar 6;19:1299-1308.
Hao K#, Lei W#, Wu H, Wu J, Yang Z, Yan S, Lu XA, Li J, Xia X, Han X, Deng W, Zhong G, Zhao ZA, Hu S*. LncRNA-Safe contributes to cardiac fibrosis through Safe-Sfrp2-HuR complex in mouse myocardial infarction. Theranostics. 2019; 9(24):7282-7297.
Fang X#, Miao S#, Yu Y, Ding F, Han X, Wu H, Zhao ZA, Wang Y, Hu S*, Lei W*. MIR148A family regulates cardiomyocyte differentiation of human embryonic stem cells by inhibiting the DLL1-mediated NOTCH signaling pathway. J Mol Cell Cardiol. 2019; 134:1-12.
Yu Y#, Qin N#, Lu XA#, Li J, Han X, Ni X, Ye L, Shen Z, Chen W, Zhao ZA*, Lei W*, Hu S*. Human embryonic stem cell-derived cardiomyocyte therapy in mouse permanent ischemia and ischemia-reperfusion models. Stem Cell Res Ther. 2019; 10(1):167.
Berry JL, Zhu W, Tang YL, Krishnamurthy P, Ge Y, Cooke JP, Chen Y, Garry DJ, Yang HT, Rajasekaran NS, Koch WJ, Li S, Domae K, Qin G, Cheng K, Kamp TJ, Ye L, Hu S, Ogle BM, Rogers JM, Abel ED, Davis ME, Prabhu SD, Liao R, Pu WT, Wang Y, Ping P, Bursac N, Vunjak-Novakovic G, Wu JC, Bolli R, Menasché P, Zhang J*. Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure. Circ Res. 2019; 124(1):161-169.
Lin S, Zhu YY, Hu W, Yang Y, Luo JM, Hu SJ, Yang ZM*. Decidual expression and regulation of fatty acid desaturase 3 during mouse decidualization. Reproduction. 2018; 156(5):429-437.
Wu H#, Zhao ZA#, Liu J#, Hao K#, Yu Y, Han X, Li J, Wang Y, Lei W, Dong N*, Shen Z*, Hu S*. Long noncoding RNA Meg3 regulates cardiomyocyte apoptosis in myocardial infarction. Gene Ther. 2018; 25(8):511-523.
Zhao ZA#, Han X#, Lei W#, Li J#, Yang Z, Wu J, Yao M, Lu XA, He L, Chen Y, Zhou B, Hu S*. Lack of Cardiac Improvement after Cardiosphere-derived Cell Transplantation in Ageing Mouse Hearts. Circ Res. 2018; 123(10):e21-e31.
Ye L#, Ni X#, Zhao ZA, Lei W, Hu S*. The application of induced pluripotent stem cells in cardiac disease modeling and drug testing. J Cardiovasc Transl Res. 2018 May 29. doi: 10.1007/s12265-018-9811-3.
Lei W#, Feng T#, Fang X, Yu Y, Yang J, Zhao ZA, Liu J, Shen Z*, Deng W*, Hu S*. Signature of circular RNAs in human induced pluripotent stem cells and derived cardiomyocytes. Stem Cell Res Ther. 2018; 9(1):56.
Yu Y#, Lei W#, Yang J#, Wei YC, Zhao ZL, Zhao ZA*, Hu S*. Functional mutant GATA4 identification and potential application in preimplantation diagnosis of congenital heart diseases. Gene. 2018; 641:349-354.
Zhao MT#, Shao NY#, Hu S#*, Ma N, Srinivasan R, Jahanbani F, Lee J, Zhang SL, Snyder MP*, Wu JC*. Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells. Circ Res. 2017; 121(11):1237-1250.
Xie Y, Wang D, Lan F, Wei G, Ni T, Chai R, Liu D, Hu S, Li M, Li D, Wang H, Wang Y. An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells. Sci Rep. 2017; 7(1):2320.
Liu Q, Lyu Z, Yu Y, Zhao ZA, Hu S, Yuan L, Chen G, Chen H. Synthetic Glycopolymers for Highly Efficient Differentiation of Embryonic Stem Cells into Neurons: Lipo- or Not? ACS Appl Mater Interfaces. 2017; 9(13):11518-11527.
Liang P, Sallam K, Wu H, Li Y, Itzhaki I, Garg P, Zhang Y, Vermglinchan V, Lan F, Gu M, Gong T, Zhuge Y, He C, Ebert AD, Sanchez-Freire V, Churko J, Hu S, Sharma A, Lam CK, Scheinman MM, Bers DM, Wu JC. Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome. J Am Coll Cardiol. 2016; 68(19):2086-2096.
Hu S*, Zhao MT, Jahanbani F, Shao NY, Lee WH, Chen H, Snyder MP, Wu JC. Effects of cellular origin on differentiation of human induced pluripotent stem cell-derived endothelial cells. JCI Insight. 2016; 1(8):e85558.
Shen H#, Wang Y#, Zhang Z, Yang J, Hu S*, Shen Z*. Mesenchymal stem cells for cardiac regenerative therapy: optimization of cell differentiation strategy. Stem Cells Int. 2015; 2015:524756.
Noman MZ, Janji B, Hu S, Wu JC, Martelli F, Bronte V, Chouaib S*. Tumor promoting effects of myeloid derived suppressor cells are potentiated by hypoxia-induced expression of miR-210. Cancer Res. 2015; 75(18):3771-87.
Lee WH#, Nguyen P#, Hu S, Liang G, Ong SG, Han L, Sanchez-Freire V, Lee AS, Vasanawala M, Segall G, Wu JC*. Variable activation of the DNA damage response pathways in patients undergoing single-photon emission computed tomography myocardial perfusion imaging. Circ Cardiovasc Imaging. 2015; 8(2):e002851.
Gu M#, Mordwinkin NM#, Kooreman NG, Lee J, Wu H, Hu S, Churko JM, Diecke S, Burridge PW, He C, Barron FE, Ong SG, Gold JD, Wu JC*. Pravastatin reverses obesity-induced dysfunction of induced pluripotent stem cell-derived endothelial cells via a nitric oxide-dependent mechanism. Eur Heart J. 2015; 36(13):806-16.
Nguyen PK#, Lee WH#, Li YF#, Hong WX, Hu S, Chan C, Liang G, Nguyen I, Ong SG, Churko J, Wang J, Altman RB, Fleischmann D, Wu JC*. Assessment of the Radiation Effects of Cardiac CT Angiography Using Protein and Genetic Biomarkers. JACC Cardiovasc Imaging. 2015; 8(8):873-84.
Wang Y#, Liang P#, Lan F#, Wu H#, Lisowski L, Gu M, Hu S, Kay MA, Urnov FD, Shinnawi R, Gold JD, Gepstein L, Wu JC*. Genome Editing of Isogenic Human Induced Pluripotent Stem Cells Recapitulates Long QT Phenotype for Drug Testing. J Am Coll Cardiol. 2014; 64(5):451-9.
Sanchez-Freire V, Lee AS, Hu S, Abilez OJ, Liang P, Lan F, Huber BC, Ong SG, Hong WX, Huang M, Wu JC*. Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells. J Am Coll Cardiol. 2014; 64(5):436-48.
de Almeida PE#, Meyer EH#, Kooreman NG#, Diecke S, Dey D, Sanchez-Freire V, Hu S, Ebert A, Odegaard J, Mordwinkin N, Brouwer TP, Lo D, Montoro D, Longaker MT, Negrin RS, Wu JC*. Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance. Nat Commun. 2014; 5:3903.
Zhu H, Hu S, Baker J*. JMJD5 regulates cell cycle and pluripotency in human embryonic stem cells. Stem Cells. 2014; 32(8):2098-110.
Hu S, Wilson KD, Ghosh Z, Han L, Wang Y, Lan F, Ransohoff KJ, Wu JC*. MicroRNA-302 increases reprogramming efficiency via repression of NR2F2. Stem Cells. 2013; 31(2):259-68.
Lister R#, Mukanel EA#, Nery JR, Urich M, Puddifoot CA, Johnson ND, Lucero J, Huang Y, Dwork AJ, Schultz MD, Yu M, Tonti-Filippini J, Pastor WA, Heyn H, Hu S, Wu JC, Rao A, Eateller M, He C, Haghighi GF, Sejnowski TJ, Behrens MM*, Ecker JR*. Global epigenomic reconfiguration during mammalian brain development. Science. 2013; 341(6146):1237905.
Huber BC#, Ransohoff JD#, Ransohoff KJ, Riegler J, Ebert A, Kodo K, Gong Y, Sanchez-Freire V, Dey D, Kooreman NG, Diecke S, Zhang WY, Odegaard J, Hu S, Gold JD, Robbins RC, Wu JC*. Costimulation-Adhesion Blockade is Superior to Cyclosporine A and Prednisone Immunosuppressive Therapy for Preventing Rejection of Differentiated Human Embryonic Stem Cells Following Transplantation. Stem Cells. 2013; 31(11):2354-63.
Lan F#, Lee AS#, Liang P#, Sanchez-Freire V, Nguyen PK, Wang L, Han L, Yen M, Wang Y, Sun N, Abilez OJ, Hu S, Ebert AD, Navarrete EG, Simmons CS, Wheeler M, Pruitt B, Lewis R, Yamaguchi Y, Ashley EA, Bers DM, Robbins RC, Longaker MT, Wu JC*. Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell. 2013; 12(1):101-13.
Su W#, Wang L#, Zhou M, Liu Z, Hu S, Tong L, Liu Y, Fan Y, Kong D, Zheng Y, Han Z, Wu JC, Xiang R*, Li Z*. Human embryonic stem cell-derived endothelial cells as cellular delivery vehicles for treatment of metastatic breast cancer. Cell Transplant. 2013; 22(11):2079-90.
Daadi MM, Hu S, Klausner J, Li Z, Sofilos M, Sun G, Wu JC, Steinberg GK*. Imaging neural stem cell graft-induced structural repair in stroke. Cell Transplant. 2013; 22(5):881-92.
Wang Y#, Zhang WY#, Hu S, Lan F, Lee AS, Huber B, Lisowski L, Liang P, Huang M, de Almeida PE, Won JH, Sun N, Robbins RC, Kay MA, Urnov FD, Wu JC*. Genome editing of human embryonic stem cells and induced pluripotent stem cells with zinc finger nuclease for cellular imaging. Circ Res. 2012; 111(12):1494-503.
Gu M#, Nguyen PK#, Lee AS, Xu D, Hu S, Plews J, Han L, Huber BC, Lee WH, Gong Y, de Almeida PE, Lyons J, Ikeno F, Pacharinsak C, Connolly AJ, Gambhir SS, Robbins RC, Longaker MT*, Wu JC*. Microfluidic single-cell analysis shows that porcine induced pluripotent stem cell-derived endothelial cells improve myocardial function by paracrine activation. Circ Res. 2012; 111(7):882-93.
Lan F#, Liu J#, Narsinh KH#, Hu S, Han L, Lee AS, Karow M, Nguyen PK, Nag D, Calos MP, Robbins RC, Wu JC*. Safe genetic modification of cardiac stem cells using a site-specific integration technique Circulation. 2012; 126(11):S20-8.
Liu J#, Narsinh KH#, Lan F#, Wang L, Nguyen PK, Hu S, Lee A, Han L, Gong Y, Huang M, Nag D, Rosenberg J, Chouldechova A, Robbins RC, Wu JC*. Early stem cell engraftment predicts late cardiac functional recovery: pre-clinical insights from molecular imaging. Circ Cardiovasc Imaging. 2012; 5(4):481-90.
Levi B#, Hyun JS#, Montoro DT#, Lo DD, Chan CK, Hu S, Sun N, Lee M, Grova M, Connolly AJ, Wu JC, Gurtner GC, Weissman IL, Wan DC, Longaker MT*. In vivo directed differentiation of pluripotent stem cells for skeletal regeneration. Proc Natl Acad Sci U S A. 2012; 109(50):20379-84.
Sun N#, Yazawa M#, Liu J, Han L, Sanchez-Freire V, Abilez OJ, Navarrete EG, Hu S, Wang L, Lee A, Pavlovic A, Lin S, Chen R, Hajjar RJ, Snyder MP, Dolmetsch RE, Butte MJ, Ashley EA, Longaker MT, Robbins RC, Wu JC*. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci Transl Med. 2012; 4(130):130ra47.
Reddy S, Zhao M, Hu DQ, Fajardo GA, Hu S, Ghosh Z, Rajagopalan V, Wu JC, Bernstein D*. Dynamic microrna expression during the transition from right ventricular hypertrophy to failure. Physiol Genomics. 2012; 44(10):562-75.
Levi B, Nelson ER, Hyun JS, Glotzbach JP, Li S, Nauta A, Montoro DT, Lee M, Commons GC, Hu S, Wu JC, Gurtner GC, Longaker MT*. Enhancement of human adipose-derived stromal cell angiogenesis through knockdown of a BMP-2 inhibitor. Plast Reconstr Surg. 2012; 129(1):53-66.
Huang M, Nguyen P, Jia F, Hu S, Gong Y, de Almeida PE, Wang L, Nag D, Kay MA, Giaccia AJ, Robbins RC, Wu JC*. Double knockdown of prolyl hydroxylase and factor-inhibiting hypoxia-inducible factor with nonviralminicircle gene therapy enhances stem cell mobilization and angiogenesis after myocardial infarction. Circulation. 2011; 124(11):S46-54.
Lee AS#, Xu D#, Nguyen PK, Nag D, Lyons JK, Han L, Hu S, Lan F, Huang M, Liu J, Narsinh KN, Long CT, de Almeida P, Levi B, Kooreman N, Bangs C, Pacharinsak C, Yeung AC, Gambhir SS, Longaker MT*, Wu JC*. Preclinical derivation and imaging of autologously transplanted canine induced pluripotent stem cells. J Biol Chem. 2011; 286(37):32697-704.
Ghosh Z#, Huang M#, Hu S#, Wilson KD, Dey D, Wu JC*. Dissecting the oncogenic and tumorigenic potential of differentiated human induced pluripotent stem cells and human embryonic stem cells. Cancer Res. 2011; 71(14):5030-9.
Levi B, James AW, Nelson ER, Hu S, Sun N, Peng M, Wu J, Longaker MT*. Studies in adipose-derived stromal cells: migration and participation in repair of cranial injury after systemic injection. Plast Reconstr Surg. 2011; 127(3):1130-40.
Narsinh KH, Sun N, Sanchez-Freire V, Lee AS, Almeida P, Hu S, Jan T, Wilson KD, Leong D, Rosenberg J, Yao M, Robbins RC, Wu JC*. Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells. J Clin Invest. 2011; 121(3):1217-21.
Li Z#, Hu S#, Ghosh Z, Han Z, Wu JC*. Functional characterization and expression profiling of human induced pluripotent stem cell- and embryonic stem cell-derived endothelial cells. Stem Cells Dev. 2011; 20(10):1701-10.
Hu S, Huang M, Li Z, Jia F, Ghosh Z, Lijkwa MA, Fasanaro P, Sun N, Wang X, Martelli F, Robbins RC, Wu JC*. MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation. 2010; 122(11):S124-31.
Wilson KD, Hu S, Venkatasubrahmanyam S, Fu JD, Sun N, Abilez OJ, Baugh JJ, Jia F, Ghosh Z, Li RA, Butte AJ, Wu JC*. Dynamic microRNA expression programs during cardiac differentiation of human embryonic stem cells: role for miR-499. Circ Cardiovasc Genet. 2010; 3(5):426-35.
Ghosh Z, Wilson KD, Wu Y, Hu S, Quertermous T, Wu JC*. Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS One. 2010; 5(2):e8975.
Su RW, Lei W, Liu JL, Zhang ZR, Jia B, Feng XH, Ren G, Hu SJ, Yang ZM
Sun N, Panetta NJ, Gupta DM, Wilson KD, Lee A, Jia F, Hu S, Cherry AM, Robbins RC, Longaker MT, Wu JC*. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci U S A. 2009; 106(37):15720-5.
Huang M, Chen Z, Hu S, Jia F, Li Z, Hoyt G, Robbins RC, Kay MA, Wu JC*. Novel minicircle vector for gene therapy in murine myocardial infarction. Circulation. 2009; 120(11):S230-7.
Hu SJ, Ren G, Liu JL, Zhao ZA, Yu YS, Su RW, Ma XH, Ni H, Lei W, Yang ZM*. MicroRNA expression and regulation in mouse uterus during embryo implantation. J Biol Chem. 2008; 283(34):23473-84.
Gao F, Lei W, Diao HL, Hu SJ, Luan LM, Yang ZM*. Differential expression and regulation of prostaglandin transporter and metabolic enzymes in mouse uterus during blastocyst implantation. Fertil Steril. 2007; 88(4): S1256-65.
Ma XH, Hu SJ, Ni H, Zhao YC, Tian Z, Liu JL, Ren G, Liang XH, Yu H, Wan P, Yang ZM*. Serial analysis of gene expression in mouse uterus at the implantation site. J Biol Chem. 2006; 281 (14):9351-60.
Ma XH, Hu SJ, Yu H, Xu LB, Yang ZM*. Differential expression of transcriptional repressor snail gene at implantation site in mouse uterus. Mol Reprod Dev. 2006; 73(2):133-41.
Chen Y, Ni H, Ma XH, Hu SJ, Luan LM, Ren G, Zhao YC, Li SJ, Diao HL, Xu X, Zhao ZA, Yang ZM*. Global analysis of differential luminal epithelial gene expression at mouse implantation sites. J Mol Endocrinol. 2006; 37(1):147-61.
1. 发明专利名称：间歇性饥饿促进心肌细胞成熟的方法，专利号：ZL202110559884.4
2. 发明专利名称：一种诱导人源动脉内皮细胞的分化方法，专利号：ZL202111154289.9
3. 发明专利名称：一种促进人多能干细胞定向分化为内皮细胞的方法，专利号：ZL201910197934.1
4. 发明专利名称：一种提高多能干细胞分化为心肌细胞的诱导方法，专利号：ZL201810123408.6
5. 发明专利名称：促进多能干细胞分化为心肌细胞成熟的方法，专利号：ZL201810122820.6
1. 《干细胞通用要求》，归口单位：中国细胞生物学学会，T/CSCB 0001-2020，2020-04-30发布，2020-08-30实施
2. 《人胚干细胞》，归口单位：中国细胞生物学学会，T/CSCB 0002-2020，2020-04-30发布，2020-08-30实施
3. 《人心肌细胞》，归口单位：中国细胞生物学学会，T/CSCB 0007-2021，2021-01-09发布，2021-04-09实施
4. 《人诱导多能干细胞》，归口单位：中国细胞生物学学会，T/CSCB 0005-2021，2021-01-09发布，2021-04-09实施
5. 《原代人肝细胞》，归口单位：中国细胞生物学学会，T/CSCB 0008-2020，2021-01-09发布，2021-04-09实施
6. 《人自然杀伤细胞》，归口单位：中国细胞生物学学会，T/CSCB 0008-2020，2022-08-30发布，2021-10-31实施
